|
一、项目简介：
1、项目概况：年产80万盒“妇一康”生物活性因子制剂。“妇一康”生物活性因子制剂是选用高活性super菌制成的广谱、高效、安全、无任何毒、副作用的微生物杀菌制剂，适用于各种妇科炎症，如各种阴道炎等。具有治疗周期短，一分钟杀灭细菌，3-6天痊愈的特点。其它抗生素类药物同时会杀灭有益菌群，从而容易引起二次感染，而本产品为纯天然生 物制剂，可保护有益菌群，并且孕妇、各年龄段患者及男性均可放心使用，具有广阔的市场前景。
2、合作方式：合资
3、项目投资总额：550万美元
4、需要外方投资内容：现汇、设备
5、建设地点：吉林高新技术产业开发区
6、项目效益分析：销售收入：850万美元税金：85万美元利润：250万美元
7、预计投资回收期：3.5年
8、项目进展情况：吉林高新区立项，项目建议书经吉林省经济贸易委员会“吉经贸投资[2001]607号”批复。产品经吉林省卫生局批准生产，批准文号：吉卫消准字[2001]第008号。
二、中方企业情况：
1、企业名称：吉林高大权生物发展有限公司
法人代表：高大权
2、企业所有制性质：私营
3、、企业基本情况：注册资本：200万美元，总固定资产：685万美元无形资产(“高大权”品牌)：6000万美元；主要产品：食品、生物制药
4、联系方式：
单位：吉林市江城网站
联系人：马天作
手机：013514426560
地址：吉林市北京路142号
邮编：132011
电话：86-432-2014042、2014043
传真：86-432-2014044
Http://www.jiangcheng.net
E-mail: web@jiangcheng.net
Project of Fuyikang Biological Active Factor Agent
1. Description of the proposed project
1-1. Main product and scale of production: annual output 800,000 boxes of Fuyikang biological active factor agent.
1-2.Characteristics of the product: Biological active factor agent Fuyikang is a microbial bactericide made of high active super bacteria. And it functions wide-spectrum, high efficiency and safe without any poisonous or side effect. It can be used for every kind of gynecological inflamination, such as every kind of vaginitis, etc. It features short curing term, and it can kill bacteria in a minute and the patient can recover within 3~6 days.
1-3. Market prospect: Other antibiotic medicine may kill the beneficial bacteria group and causes the secondary infection. This product is the pure natural biological agent and can protect the beneficial bacteria group and it can be used by pregnant woman, any age patients, and even male safely. It has a broad market prospect.
1-4. Total investment: US$5,500,000
1-5. Land coverage: Up to 30,000s.m, plant premises: 14,000s.m, including 5,000s.m of GMP standard plants.
1-6. Proposed ownership structure: foreign partner: US$2,400,000, 43.6%, by cash
Chinese partner: US$3,100,000, 56.4%, by cash, land and plant.
7. Form of cooperation: Joint venture
8. Economic benefit analysis: annual sales income: US$8,500,000; annual tax: US$850,000;
annual profit: US$2,500,000;. payback period: 3.5 year
9. Project site: Jilin Hi-tech Zone
10. Available reports, studies: The project proposal book has been approved and replied by the document J.J.M.T.Z. [2001] No. 607, issued by Jilin Province Committee of Economy and Trade. The product has been approved for production by Jilin Province Bureau of Health, and the approved document is J.W.X.Z.No. [2001] 008. .
2. Description of Chinese partner:
2-1. Company name: Jilin Gaodaquan Biology Development Co., Ltd.
2-2. Company data: Registered capital: US$2,000,000; fixed assets: US$6,850,000; Invisible assets of the brand Gaodaquan: US $60,000,000
2-3. Main products: food, pharmaceutical
3. Contact mode:
Company: JiLin City JiangCheng Network
Name: Ma Tianzuo
Mobile: 013514426560
Address: No.142 BeiJing Road in JiLin City
P.C.: 132013
Tel: 86-432- 2014042、2014043
Fax: 86-432-2014044
Http://www.jiangcheng.net
E-mail: web@jiangcheng.net
| 
